Advantage ORE's Junior partner continues to slump after big dips last week. Can anyone put a reason as to why?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025